FdaApplication
NDA 208653
Identifiers
- fda_app_no: NDA208653
Properties
| Property | Value |
|---|---|
| applicant_name | ZEVRA THERAPEUTICS |
| application_type | NDA |
| approval_date | 2018-02-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | 325MG;EQ 6.12MG BASE | TABLET;ORAL |
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | 325MG;EQ 4.08MG BASE | TABLET;ORAL |
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | 325MG;EQ 8.16MG BASE | TABLET;ORAL |
3 products